Schering-Plough is a global pharmaceutical company with leading prescription medicines and consumer and animal health products. Today, the Company is continuing a transformation under a five phase Action Agenda that began in 2003.
Our goal is to provide a steady flow of innovative science-based medicines and services, while earning the trust of physicians, patients and other customers we serve. By doing this with excellence, we intend to build the foundation for long-term sustainable growth.
We are committed to business integrity, quality and compliance in everything we do.
Schering-Plough Animal Health New Zealand, manufactures and distributes bacterial vaccines, (primarily clostridal vaccines), which protect against a variety of diseases in sheep, cattle, deer and pigs. A total of 29 different vaccines are manufactured at Upper Hutt.
Manufacturing process is by anaerobic and aerobic bacterial fermentation using scale up processes.
85% of product manufactured at Upper Hutt is exported to United States, Canada, Mexico, Europe, Australia, the Middle East, Africa and South America.
The Upper Hutt production facility was commissioned in 1993, and meets all regulatory requirements for our global markets.
Read more about this employer
